CeriBell, Inc. (CBLL) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Sunnyvale, CA, United States. Le PDG actuel est Xingjuan Chao.
CBLL a date d'introduction en bourse 2024-10-11, 281 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $772.77M.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
